Why the study?
Does halothane anesthesia compared to other general anesthetic agents affect the incidence of fatal massive hepatic necrosis and overall death rate in patients undergoing general anesthesia?
Does halothane anesthesia compared to other general anesthetic agents affect the incidence of fatal massive hepatic necrosis and overall death rate in patients undergoing general anesthesia?
There is a wide, 24-fold variation in six-week postoperative death rates across different institutions following general anesthesia.
Answers are grounded in this paper and cite their sources.
Institutional variation in postoperative mortality cautions against uniform outcome expectations; leaves open whether anesthetic agents drive differences.
The National Halothane Study was designed to examine the possible association of halothane anesthesia and postoperative massive hepatic necrosis. It was a retrospective survey of the incidence of fatal massive hepatic necrosis and overall death rate following general anesthesia in 34 hospitals for the four-year period from 1959 through 1962. A summary of the observed incidences of liver necrosis and mortality following halothane anesthesia and following use of other general anesthetic agents has been published inThe Journal.1One important by-product of the study was the finding of large differences in postoperative mortality occurring among the participating institutions. The following communication represents a summary of the statistical analysis of these institutional differences and a discussion of their possible significance. Death rates for the six-week period following surgery varied widely among the 34 institutions cooperating in this study. These death rates ranged from 0.27% to 6.40%, a 24-fold ratio. In
No takes yet. Share an insight, caveat, or question.
L. E. Moses (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: